Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study.… Read more The PCSK9-REACT study
Author: siriomedicine
PCSK9 antibodies for ACS: A Narrative Review
Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies for Acute Coronary Syndrome: A Narrative Review. Navarese EP, Kolodziejczak M, Kereiakes DJ,… Read more PCSK9 antibodies for ACS: A Narrative Review
PCSK9 antibodies: Critical considerations of mortality and neurocognitive findings
Role of PCSK9 antibodies in cardiovascular disease: Critical considerations of mortality and neurocognitive findings from the current literature. Kołodziejczak M,… Read more PCSK9 antibodies: Critical considerations of mortality and neurocognitive findings
From proprotein convertase subtilisin/kexin type 9 to its inhibition: state-of-the-art and clinical implications
From proprotein convertase subtilisin/kexin type 9 to its inhibition: state-of-the-art and clinical implications Navarese EP, Kołodziejczak M, Dimitroulis D, Wolff… Read more From proprotein convertase subtilisin/kexin type 9 to its inhibition: state-of-the-art and clinical implications
Anticoagulant strategies for ACS: network meta-analysis of 42 randomised trials involving 117,353 patients
Comparative efficacy and safety of anticoagulant strategies for acute coronary syndromes. Comprehensive network meta-analysis of 42 randomised trials involving 117,353… Read more Anticoagulant strategies for ACS: network meta-analysis of 42 randomised trials involving 117,353 patients
TCTMD: Meta-analysis Supports Benefit of Complete Revascularization in STEMI
Key Points: Meta-analysis compares revascularization strategies in STEMI patients with multivessel disease Decrease in MACE with complete revascularization spurred by… Read more TCTMD: Meta-analysis Supports Benefit of Complete Revascularization in STEMI
heartwire NEWS: ‘Guarded Enthusiasm’ Builds for PCSK9 Inhibitors
GAITHERSBURG, MD — Over 2 days next week the US Food and Drug Administration (FDA) will hear from a panel… Read more heartwire NEWS: ‘Guarded Enthusiasm’ Builds for PCSK9 Inhibitors
PCSK9 antibodies meta-analysis in media
More Preliminary Signs That The New Cholesterol Drugs May Improve Outcomes New drugs show promise for treating high cholesterol PCSK9 Inhibitors… Read more PCSK9 antibodies meta-analysis in media
Annals of Internal Medicine: Mortality reduction with PCSK9 Antibodies
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis Eliano Pio Navarese, Michalina Kołodziejczak,… Read more Annals of Internal Medicine: Mortality reduction with PCSK9 Antibodies
BMJ meta-analysis: optimal DAPT duration after PCI with DES
Available under Open Access Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised… Read more BMJ meta-analysis: optimal DAPT duration after PCI with DES
